Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Neuropharmacology|February 1, 1995
1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slicesM A Desai, M J Valli, J A Monn, et al.
Molecular Pharmacology|October 1, 1995
Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporterM A Desai, J P Burnett, N G Mayne, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|March 1, 1995
Reversible and irreversible neuronal injury induced by intrahippocampal infusion of the mGluR agonist 1S,3R-ACPD in the ratD D Schoepp, J P Tizzano, R A Wright, et al.
Journal of Neural Transmission. General Section|January 1, 1991
Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonistD D Schoepp, P L Ornstein, C R Salhoff, et al.
Molecular Pharmacology|August 1, 1990
Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acidD D Schoepp, B G Johnson, E C Smith, et al.
European Journal of Pharmacology|January 3, 1994
The NMDA receptor agonist DL-(tetrazol-5-yl)glycine is a highly potent excitotoxinD D Schoepp, W H Lunn, C R Salhoff, et al.
British Journal of Pharmacology|July 1, 1996
Pharmacological characterization of desensitization in a human mGlu1 alpha-expressing non-neuronal cell line co-transfected with a glutamate transporterM A Desai, J P Burnett, N G Mayne, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 1999
Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the ratA G Lam, J A Monn, D D Schoepp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2004
The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in ratsI Feinberg, D D Schoepp, K-C Hsieh, et al.
Neuropharmacology|May 30, 2001
Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockadeJ Cartmell, K W Perry, C R Salhoff, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Neuropharmacology|February 1, 1995
1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slicesM A Desai, M J Valli, J A Monn, et al.
Molecular Pharmacology|October 1, 1995
Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporterM A Desai, J P Burnett, N G Mayne, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|March 1, 1995
Reversible and irreversible neuronal injury induced by intrahippocampal infusion of the mGluR agonist 1S,3R-ACPD in the ratD D Schoepp, J P Tizzano, R A Wright, et al.
Journal of Neural Transmission. General Section|January 1, 1991
Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonistD D Schoepp, P L Ornstein, C R Salhoff, et al.
Molecular Pharmacology|August 1, 1990
Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acidD D Schoepp, B G Johnson, E C Smith, et al.
European Journal of Pharmacology|January 3, 1994
The NMDA receptor agonist DL-(tetrazol-5-yl)glycine is a highly potent excitotoxinD D Schoepp, W H Lunn, C R Salhoff, et al.
British Journal of Pharmacology|July 1, 1996
Pharmacological characterization of desensitization in a human mGlu1 alpha-expressing non-neuronal cell line co-transfected with a glutamate transporterM A Desai, J P Burnett, N G Mayne, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 1999
Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the ratA G Lam, J A Monn, D D Schoepp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2004
The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in ratsI Feinberg, D D Schoepp, K-C Hsieh, et al.
Neuropharmacology|May 30, 2001
Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockadeJ Cartmell, K W Perry, C R Salhoff, et al.
Pageof 13